Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IDEA: 3 vs 6 Months of Adjuvant FOLFOX or CAPOX for Stage III Colon Cancer
NCT00958737Phase 3Unknown
- Sponsor
- GERCOR
- Start
- May 2009
- Primary completion
- Jan 2020
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of oxaliplatin, fluorouracil, folinic acid, capecitabine in colon cancer, sponsored by GERCOR. Status: unknown.
02
Drugs
oxaliplatinfluorouracilfolinic acidcapecitabine
03
Conditions
colon cancer
Beyond the preview
Go deeper on NCT00958737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00958737.